Abstracts Archive - Page 801 of 1683 - ATC Abstracts

2018 American Transplant Congress
Is Percent Exception at Transplant a Driver of MELD Inflation?
D. Schladt,¹ J. Snyder,¹ A. Israni,¹ W. Kim,² J. Lake.³
¹SRTR, Minneapolis, MN; ²Stanford University, Stanford, CA; ³Univ of Minnesota, Minneapolis, MN.
Before 2016, the proportion of deceased donor liver recipients with an exception status at liver transplant (LT) correlated strongly with median MELD at transplant (MMaT)…
2018 American Transplant Congress
When Does Donor Age Matter? A Review of over 70,000 Liver Transplants
D. Yoeli, E. Pan, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss, A. Rana.
Surgery, Baylor College of Medicine, Houston, TX.
Background: Past studies on donor age in liver transplantation have largely relied on binary groups (i.e., young vs. old) with arbitrarily defined cut-offs. The aim…
2018 American Transplant Congress
Waitlist Candidates Who Travel for Liver Transplantation and the Donor Organs They Receive
J. Ge, J. Lai.
Medicine, UCSF, San Francisco, CA; Medicine, UCSF, San Francisco, CA.
Background:Geographic disparities in access to liver transplantation (LT) has led to candidates seeking LT outside their home UNOS region (“Travelers”). Little is known about their…
2018 American Transplant Congress
Development and Validation of Nomogram to Predict Primary Non Function in Liver Transplant Recipients Using Donation after Cardiac Death Donor Graft
Z. Guo, J. Zeng, Q. Zhao, B. Chen, Z. Zhang, L. Wang, X. He.
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Primary non function(PNF) is a severe complication after liver transplantation which causes recipient death or re-transplantation in a short term. PNF occurs more common in…
2018 American Transplant Congress
Donor Hepatectomy Time in Donation after Circulatory Death Donors is an Independent Risk Factor for the Development of Biliary Strictures and Early Graft Loss after Transplantation
O. van Leeuwen,¹ M. van Reeven,² M. Fujiyoshi,¹ V. de Meijer,¹ R. de Kleine,¹ M. de Boer,¹ J. de Jonge,² J. Ijzermans,² W. Polak,² R. Porte.¹
¹Department of Surgery, University Medical Center Groningen, Groningen, Netherlands; ²Department of Surgery, Erasmus Medical Center, Rotterdam, Netherlands.
Introduction: Liver transplantation (LT) from donors after circulatory death (DCD) is associated with an increased risk of non-anastomotic biliary strictures (NAS) and early graft loss…
2018 American Transplant Congress
Regional Variation in the Outcomes of MELD-Na Based Liver Allocation
L. Chau,¹ D. Moonka,² K. Collins,¹ M. Rizzari,¹ A. Yoshida,¹ M. Abouljoud,¹ S. Nagai.¹
¹Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; ²Gastroenterology, Henry Ford Hospital, Detroit, MI.
Introduction: While there is known geographic discrepancy in waitlist and transplant outcomes in the MELD era, there is a paucity in understanding of these variations…
2018 American Transplant Congress
Impact of On-Site Overestimation of Macrosteatosis on Donor Liver Biopsy
M. Wright, J. Seal, L. De Gregorio, H. Bohorquez, D. Bruce, E. Bugeaud, I. Carmody, A. Mathur, D. Sonnier, G. Galliano, I. Oliva, L. Bratton, G. Loss.
Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans.
Introduction: Estimation of hepatic steatosis is an important variable in determining suitability of a donor liver allograft for transplantation. Differentiation between and quantification of macro-…
2018 American Transplant Congress
Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes
L. De Gregorio,¹ E. Bugeaud,¹ G. Galliano,² H. Bohorquez,¹ D. Bruce,¹ I. Carmody,¹ A. Cohen,¹ J. Seal,¹ D. Sonnier,¹ A. Mathur,¹ G. Loss.¹
¹Abdominal Transplant Surgery, Ochsner Clinic Foundation, New Orleans, LA; ²Pathology, Ochsner Clinic Foundation, New Orleans, LA.
INTRODUCTIONGraft steatosis is a risk factor for early allograft dysfunction (EAD) and is thought to portend inferior transplant outcomes. The impact of total steatosis, combining…
2018 American Transplant Congress
Donor and Procedural Variability in DCD Liver Transplant: Is It Time to Come to a Consensus?
L. Ruffolo, M. Balceniuk, R. Hernandez Alejandro.
Department of Surgery, University of Rochester Medical Center on Behalf of the IDOL Consortium, Rochester, NY.
Background:Donation after cardiocirculatory death liver transplantation (DCD LT) has re-emerged in part because of insufficient grafts for patients on waiting lists. Unfortunately, DCD LT has…
2018 American Transplant Congress
Real-Time Expert Evaluation of Liver Biopsy for Transplant: The Significance of Smartphone and Microscope Adapter in Telepathology
N. Bath,¹ X. Wang,² J. Bledsoe,² M. Thijssen,¹ A. Ahearn,¹ B. Movahedi,¹ A. Bozorgzadeh,¹ P. Martins.¹
¹Surgery, University of Massachusetts, Worcester, MA; ²Pathology, University of Massachusetts, Worcester, MA.
Introduction: Liver biopsy at the time of procurement plays a crucial role in the acceptance of marginal grafts. Local pathologists and transplant surgery fellows are…